These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19803002)

  • 1. Trial of ceftazidime efficacy in respiratory infections at two dose levels.
    Feist H; Vetter N; Muhar F; Williams KJ; Brandstetter HJ; Ho I
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():299-301. PubMed ID: 19803002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience in the treatment of lower respiratory tract infections with ceftazidime.
    Pettersson T; Ahvonen P; Storgårds E
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():303-5. PubMed ID: 19803003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of ceftazidime in intractable respiratory tract infections].
    Takenaka S; Fukuda K; Kimura T; Shima K; Ushijima M; Egashira Y; Ikeda S; Hiraoka T; Higuchi S; Fujise T
    Jpn J Antibiot; 1989 Dec; 42(12):2555-65. PubMed ID: 2693754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with ceftazidime for lower respiratory tract infections.
    De Sandre G; Corrocher RI; Gabrielli GB; Ho I
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():307-10. PubMed ID: 19803004
    [No Abstract]   [Full Text] [Related]  

  • 5. [A clinical study of combined therapy of aspoxicillin and ceftazidime on intractable respiratory infections].
    Yamaki K; Suzuki R; Taki F; Takagi K; Satake T; Mizuno K; Baba K; Aihara H; Mori M; Yamada K
    Jpn J Antibiot; 1992 Oct; 45(10):1282-94. PubMed ID: 1479680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
    Colardyn F
    J Chemother; 1995 Jun; 7 Suppl 2():129-35. PubMed ID: 8622101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Position of ceftazidime in respiratory diseases.
    Ando' F; Girbino G; Ferrara F
    Drugs Exp Clin Res; 1985; 11(6):369-72. PubMed ID: 3915288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.
    Vozza A; Zerman AM; Bertoni L; Cattini GC; Tosto L; Greco N; Romano F; Panebianco R; Benedetti M
    J Hosp Infect; 1990 Apr; 15 Suppl A():87-9. PubMed ID: 1971652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous fleroxacin versus ceftazidime in the treatment of acute nonpneumococcal lower respiratory tract infections.
    Farkas SA
    Am J Med; 1993 Mar; 94(3A):142S-149S. PubMed ID: 8452171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study on ceftazidime in the treatment of intractable respiratory infections].
    Miyatake H; Takagi K; Yamaki K; Gonda H; Watanabe H; Satake T; Suzuki R; Mizuno K; Aihara H; Hara M
    Jpn J Antibiot; 1990 Jun; 43(6):1164-73. PubMed ID: 2232147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ceftazidime in severe Gram-negative infections--a preliminary study.
    Clumeck N; Vanlaethem Y; Gordts B; Jaspar N; Butzler JP
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():317-21. PubMed ID: 19803007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections.
    Chaudhary M; Shrivastava SM; Sehgal R
    Curr Clin Pharmacol; 2009 Jan; 4(1):62-6. PubMed ID: 19149503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
    Khan FA; Basir R
    Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime in the treatment of lower respiratory tract infection.
    Peirce TH; Vig SJ; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():21-5. PubMed ID: 6352621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftazidime: therapeutic results in various infections and kinetic studies.
    Daikos GK; Kosmidis J; Stathakis C; Giamarellou H; Douzinas E; Kastanakis S; Papathanassiou B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():331-7. PubMed ID: 19803010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ceftazidime in common infections in childhood. Experience in 262 cases].
    Fanos V; Fostini R; Panebianco R; Danieli D
    Clin Ter; 1991 Jun; 137(5):327-32. PubMed ID: 1832605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin in treatment of respiratory bacterial infections.
    Bonora V; Lozano C; Santos M; Paz M; Baguena J; Gobernado M
    Chemotherapy; 1977; 23 Suppl 1():337-41. PubMed ID: 832534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal dosage of ceftazidime for severe lower respiratory tract infections.
    Cade JF; Presneill J; Sinickas V; Hellyar A
    J Antimicrob Chemother; 1993 Oct; 32(4):611-22. PubMed ID: 8288503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A pharmacokinetic and clinical evaluation of ceftazidime in neonates and premature infants. A study of ceftazidime in the perinatal co-research group].
    Fujii R; Hashira S; Arimasu O; Fujita K; Murono K; Sakata H; Kakehashi H; Oka T; Kaeriyama M; Yoshioka H
    Jpn J Antibiot; 1986 Aug; 39(8):2048-67. PubMed ID: 3540339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.